This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Michael E Dodge: Innovator in Protein Signalling Inhibitors
Introduction
Michael E Dodge is a notable inventor based in Irving, TX (US). He has made significant contributions to the field of protein signalling, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing compounds that can inhibit the Wnt protein signalling pathway.
Latest Patents
Dodge's latest patents revolve around WNT protein signalling inhibitors. The present invention generally relates to protein signalling. In particular, the compounds disclosed are designed to inhibit the Wnt protein signalling pathway. Such compounds may be utilized in the treatment of various Wnt protein signalling-related diseases and conditions, including cancer, degenerative diseases, type II diabetes, and osteopetrosis.
Career Highlights
Michael E Dodge is affiliated with the University of Texas System, where he continues to advance research in his field. His work has garnered attention for its potential applications in treating serious health conditions.
Collaborations
Some of his notable coworkers include Lawrence Lum and Michael G Roth, who contribute to the collaborative efforts in research and development.
Conclusion
Michael E Dodge's innovative work in protein signalling inhibitors showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various diseases significantly.